市场调查报告书
商品编码
1309836
基因合成市场 - 按方法(固相合成)、按服务(抗体 DNA 合成)、按应用(疫苗开发)、按终端用途(学术研究机构、生物制药公司)划分,以及 2023 - 2032 年预测Gene Synthesis Market - By Method (Solid-phase Synthesis), By Services (Antibody DNA Synthesis), By Application (Vaccine Development) By End-use (Academic and Research Institutes, Biopharmaceutical Companies,) & Forecast 2023 - 2032 |
2023-2032 年,全球基因合成市场规模将呈现可喜的增长。
药物发现、基因工程和合成生物学等各种研究应用对合成基因的需求不断增长,推动了市场的增长。定制设计和合成具有所需序列和功能的基因的能力彻底改变了分子生物学研究。基因合成技术的进步,如高通量合成平台和改进的 DNA 测序方法,提高了基因合成的效率和准确性,使基因合成更容易获得,更具成本效益。
此外,医疗保健和生物技术行业越来越多地采用基因治疗和基因工程方法,也推动了对基因合成服务的需求。此外,学术机构、制药公司和合同研究组织之间的合作也促进了合成基因的开发和商业化,进一步推动了市场的增长。
整个基因合成市场份额根据方法、服务、应用、终端用途和地区进行划分。
在方法方面,到 2032 年,基于 PCR 的酶合成行业将迎来可观的增长。PCR(聚合酶链反应)是分子生物学研究中一种用途广泛的技术,因此成为酶合成的首选方法。PCR 可以快速、特异地扩增目标基因,从而高效地生产出具有所需特性的酶。此外,PCR 技术的进步,如高保真聚合酶和优化的反应条件,提高了酶合成的准确性和效率,进一步推动了酶合成的需求。
就服务而言,到 2032 年,病毒 DNA 合成的市场份额将录得可观的估值。病毒 DNA 合成对疫苗开发、基因治疗和病毒载体生产等各种应用至关重要。基因合成技术的进步使设计和生成定制的病毒 DNA 构建体变得更加容易和更具成本效益。此外,基因递送系统对病毒载体的需求不断增加,以及人们对基于病毒的研究的兴趣日益浓厚,都促使对病毒 DNA 合成服务的需求不断上升。
根据应用领域,到 2032 年,疫苗开发领域的基因合成市场价值将显著扩大。基因合成可快速、精确地生成编码疫苗抗原的病毒或细菌基因。这样就能生产出模拟目标病原体的重组蛋白质或核酸,有助于疫苗的配制。此外,基因合成还有助于新型候选疫苗的开发和现有疫苗的优化,从而推动疫苗研究的发展并应对新出现的传染病。
从 2023 年到 2032 年,欧洲基因合成行业将呈现可观的复合年增长率。分子生物学、遗传学和合成生物学等领域日益增多的研发活动推动了对基因合成服务的需求。其次,政府重点支持生物技术和生命科学领域的倡议,以及学术机构和行业参与者之间的合作,将推动业务增长。此外,基因合成技术的进步和对个性化医疗的日益关注也进一步推动了欧洲基因合成市场的扩张。
Global Gene Synthesis Market size will exhibit commendable growth over 2023-2032.
The growing demand for synthetic genes in various research applications, such as drug discovery, genetic engineering, and synthetic biology, is fueling market growth. The ability to custom-design and synthesize genes with desired sequences and functionalities has revolutionized molecular biology research. Advancements in gene synthesis technologies, such as high-throughput synthesis platforms and improved DNA sequencing methods, have increased the efficiency and accuracy of gene synthesis, making it more accessible and cost-effective.
Additionally, the increasing adoption of gene therapy and genetic engineering approaches in healthcare and biotechnology industries is driving the demand for gene synthesis services. Furthermore, collaborations between academic institutions, pharmaceutical companies, and contract research organizations are facilitating the development and commercialization of synthetic genes, further propelling market growth.
The overall gene synthesis market share is segregated based on methods, services, application, end-use, and region.
With regard to method, the PCR based enzyme synthesis industry will witness considerable growth through 2032. PCR (polymerase chain reaction) is a versatile and widely used technique in molecular biology research, making it a preferred method for enzyme synthesis. PCR allows for rapid and specific amplification of target genes, enabling efficient production of enzymes with desired characteristics. Additionally, advancements in PCR technology, such as high-fidelity polymerases and optimized reaction conditions, have improved the accuracy and efficiency of enzyme synthesis, further driving its demand.
In terms of services, the viral DNA synthesis market share will record a decent valuation by 2032. Viral DNA synthesis is crucial for various applications, including vaccine development, gene therapy, and viral vector production. Advances in gene synthesis technologies have made it easier and more cost-effective to design and generate custom viral DNA constructs. Further, the increasing need for viral vectors in gene delivery systems and the growing interest in viral-based research have contributed to the rising demand for viral DNA synthesis services.
Based on application, the gene synthesis market value from the vaccine development segment will register notable expansion through 2032. Gene synthesis enables the rapid and precise generation of viral or bacterial genes that encode vaccine antigens. This allows for the production of recombinant proteins or nucleic acids that mimic the target pathogen, aiding in vaccine formulation. This apart, gene synthesis facilitates the development of novel vaccine candidates and the optimization of existing ones, contributing to the advancement of vaccine research and the response to emerging infectious diseases.
Europe gene synthesis industry will exhibit a decent CAGR from 2023 to 2032. Increasing research and development activities in fields like molecular biology, genetics, and synthetic biology are driving the demand for gene synthesis services. Secondly, government initiatives focused on supporting biotechnology and life sciences sectors, in line with collaborations between academic institutions and industry players, will fuel business growth. Additionally, advancements in gene synthesis technologies and a rising focus on personalized medicine are further propelling the expansion of the gene synthesis market in Europe.